Press Releases

April 1, 2020
First new device cleared for home hemodialysis in 15 years   SAN JOSE, Calif.–(BUSINESS WIRE)– Outset Medical, a leading med tech innovator delivering first-of-its-kind technology into the growing global dialysis market, today announced the Food and Drug Administration (FDA) cleared the Tablo
February 4, 2020
Financing to Support Commercial Acceleration of the Tablo® Hemodialysis System, an Enterprise Solution Designed to Reduce the Cost and Complexity of Dialysis SAN JOSE, Calif., — Outset Medical, a leading medtech innovator delivering first-of-its-kind technology into the growing global dialysis